Business Development Manager (Pharma Commercial & Real-World Data)
Boost your chances before you apply.
Massive Bio
VT
Summary
The Business Development Manager will own the full sales cycle for the company's Pharma Commercial and Real-World Data portfolio. They will build relationships with key stakeholders in pharmaceutical companies to drive sales and expand the reach of precision medicine solutions.
Job Description
About Massive Bio
Every cancer patient deserves access to treatment options. Massive Bio is an AI-powered precision medicine platform transforming how cancer patients discover and access clinical trials by eliminating the barriers of geography, financial constraints, and information asymmetry that have historically limited enrollment.
Founded in 2015 and headquartered in US, Massive Bio is scaling its impact globally by powering operations across multiple countries and bringing innovative cancer treatment options to a rapidly growing and diverse population of patients. Through our proprietary AI platform, we connect individuals to clinical trials worldwide and partner with leading pharmaceutical companies, contract research organizations (CROs), and healthcare systems to accelerate drug development and expand equitable access to cutting-edge therapies.
About the Opportunity
Massive Bio's pharma offerings span the full journey from clinical development to in-market performance, across Clinical, Commercial, and Real World Data solutions. This role owns commercial growth of our Pharma Commercial and Real World Data portfolio, including the Nexus Pulse platform, with leading pharmaceutical companies in oncology. You will own the full sales cycle from first conversation to signed agreement, working closely with company leadership throughout.
We are looking for someone who sells, or has sold, pharma commercial and real-world data solutions and can open doors with the right stakeholders from day one.
This is a contractor position with the potential to convert to full-time employment.
Key Responsibilities
• Own the full sales cycle for Massive Bio's Pharma Commercial and Real World Data portfolio, from prospecting through negotiation and close.
• Drive sales of our commercial solutions across areas including alerts and triggers, HCP targeting and prescription, brand strategy and execution, sales force optimization, and field deployment.
• Position our Real World Data solutions, spanning longitudinal outcomes intelligence, biomarker and population insights, and post-market evidence generation, with Medical Affairs and Precision Medicine units.
• Build trusted relationships with commercial, brand, omnichannel, field operations, Medical Affairs, and Precision Medicine stakeholders at leading pharmaceutical companies.
• Partner closely with company leadership on deal strategy, proposals, and negotiations.
• Bring market and client feedback to leadership to sharpen offerings and positioning.
Candidate Profile & Qualifications
Required:
• Proven track record selling pharma commercial or real-world data solutions to pharmaceutical companies.
• Established relationships among pharma commercial and Medical Affairs decision-makers.
• Ability to run complex, multi-stakeholder pharma sales cycles.
• Comfortable in an entrepreneurial, build-mode environment.
Preferred:
• Oncology experience.
• Background at a data, analytics, or pharma commercialization services company.
• Familiarity with precision medicine workflows.
Massive Bio is a health-tech company transforming how cancer patients access clinical trials.
Operating in 17 countries across North America, Europe, and LATAM, we use proprietary AI technology to match patients to the most appropriate clinical trials—regardless of location, income, or cancer type.
We partner with pharmaceutical companies, CROs, and healthcare institutions to accelerate oncology trial enrollment, reduce dropout rates, and deliver real-world evidence.
💠 200K+ patients onboarded
💠 60+ pharma and CRO customers
💠 130+ strategic partners
💠 Founding member of CancerX & participant in the White House Cancer Moonshot
Explore how we simplify trial access and optimize recruitment across the oncology ecosystem.
🔗 Learn more: www.massivebio.com
Massive Bio was named after three converging revolutions: massive parallel sequencing, massive parallel computing, and the emerging ability to engineer biology itself. We started with symbolic AI before it was fashionable, and evolved into neurosymbolic systems that orchestrate data, computation, and biology—at scale—to bring precision oncology to patients.
Founded
2014
Company size
51-200 employees
Industry
Hospitals and Health Care
Org type
Privately Held
Headquarters
Istanbul
Massive Bio is a health-tech company transforming how cancer patients access clinical trials.
Operating in 17 countries across North America, Europe, and LATAM, we use proprietary AI technology to match patients to the most appropriate clinical trials—regardless of location, income, or cancer type.
We partner with pharmaceutical companies, CROs, and healthcare institutions to accelerate oncology trial enrollment, reduce dropout rates, and deliver real-world evidence.
💠 200K+ patients onboarded
💠 60+ pharma and CRO customers
💠 130+ strategic partners
💠 Founding member of CancerX & participant in the White House Cancer Moonshot
Explore how we simplify trial access and optimize recruitment across the oncology ecosystem.
🔗 Learn more: www.massivebio.com
Massive Bio was named after three converging revolutions: massive parallel sequencing, massive parallel computing, and the emerging ability to engineer biology itself. We started with symbolic AI before it was fashionable, and evolved into neurosymbolic systems that orchestrate data, computation, and biology—at scale—to bring precision oncology to patients.
Founded
2014
Company size
51-200 employees
Industry
Hospitals and Health Care
Org type
Privately Held
Headquarters
Istanbul